Press Releases

Results 361-370 of 426

Baylor Sammons Cancer Center Joins as Clinical Trial Site for Actinium’s Actimab-A Clinical Trial

Jul 30, 2014

CORRECTING and REPLACING Actinium Pharmaceuticals, Inc. Launches Development of Antibody Actinium-225 Labeling Construct To Support Third Clinical Program

Jul 16, 2014

Actinium Announces Exercise of Greenshoe Option

Jul 10, 2014

Baylor Oncology Medical Director Joins Actinium’s Iomab-B Scientific Advisory Board

Jul 7, 2014

Actinium Joins Russell 3000®, Russell 2000®, Russell Global, and Russell Micro-Cap® Indexes

Jul 1, 2014

Actinium Closes Public Offering of Common Shares

Jun 30, 2014

Preeminent Oncology Clinicians from Leading Cancer Centers Join Actinum’s Newly Established Iomab-B Scientific Advisory Board

Jun 26, 2014

Actinium Prices $12.5 Million Public Offering of Common Shares

Jun 25, 2014

Actinium Announces Proposed Public Offering of Common Shares

Jun 24, 2014

Actinium’s Actimab-A and Alpha-Particle Immunotherapy Platform Further Validated at Society for Nuclear Medicine Annual Meeting

Jun 24, 2014